New role for the protein tyrosine phosphatase DEP-1 in Akt activation and endothelial cell survival

Molecular and Cellular Biology

Volumn 29, Issue 1, 2009, Pages 241-253

  Chabot, Catherine ^a   Spring, Kathleen ^a   Gratton, Jean Philippe ^b,d   Elchebly, Mounib ^c,d   Royal, Isabelle ^a,d,e  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^c UNIVERSITY OF MONTREAL   (Canada)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

^e NOTRE DAME HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; CADHERIN; MUTANT PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN GAB1; PROTEIN KINASE B; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE DEP 1; TYROSINE; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; GAB1 PROTEIN, HUMAN; PHOSPHOTYROSINE; PROTEIN TYROSINE KINASE; PTPRJ PROTEIN, HUMAN; RECEPTOR LIKE PROTEIN TYROSINE PHOSPHATASE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; VASCULOTROPIN A;

ARTICLE; AUTOPHOSPHORYLATION; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; COMPLEX FORMATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; BIOLOGICAL MODEL; CELL DEATH; CELL LINE; CHEMISTRY; CYTOLOGY; DRUG EFFECT; ENZYME SPECIFICITY; ENZYMOLOGY; GENE SILENCING; METABOLISM; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN SECONDARY STRUCTURE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CELL DEATH; CELL LINE; CELL SURVIVAL; ENDOTHELIAL CELLS; ENZYME ACTIVATION; GENE SILENCING; HUMANS; MODELS, BIOLOGICAL; PHOSPHORYLATION; PHOSPHOTYROSINE; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 3; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; SUBSTRATE SPECIFICITY; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 58149457090     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.01374-08     Document Type: Article

References (55)

1. Abu-Ghazaleh, R., J. Kabir, H. Jia, M. Lobo, and I. Zachary. 2001. Src mediates stimulation by vascular endothelial growth factor of the phosphorylation of focal adhesion kinase at tyrosine 861, and migration and antiapoptosis in endothelial cells. Biochem. J. 360:255-264.
2. Ackah, E., J. Yu, S. Zoellner, Y. Iwakiri, C. Skurk, R. Shibata, N. Ouchi, R. M. Easton, G. Galasso, M. J. Birnbaum, K. Walsh, and W. C. Sessa. 2005. Akt1/protein kinase Bα is critical for ischemic and VEGF-mediated angiogenesis. J. Clin. Investig. 115:2119-2127.
3. Benjamin, L. 2000. The controls of microvascular survival. Cancer Metastasis Rev. 19:75-81.
4. Berset, T. A., E. F. Hoier, and A. Hajnal. 2005. The C. elegans homolog of the mammalian tumor suppressor Dep-1/Scc1 inhibits EGFR signaling to regulate binary cell fate decisions. Genes Dev. 19:1328-1340.
5. Blanes, M. G., M. Oubaha, Y. Rautureau, and J.-P. Gratton. 2007. Phosphorylation of tyrosine 801 of the VEGFR-2 is necessary for AKT-dependent eNOS activation and nitric oxide release from endothelial cells. J. Biol. Chem. 282:10660-10669.
6. Borges, L. G., R. A. Seifert, F. J. Grant, C. E. Hart, C. M. Disteche, S. Edelhoff, F. F. Solca, M. A. Lieberman, V. Lindner, E. H. Fischer, S. Lok, and D. F. Bowen-Pope. 1996. Cloning and characterization of rat density-enhanced phosphatase-1, a protein tyrosine phosphatase expressed by vascular cells. Circ. Res. 79:570-580.
7. Carmeliet, P., and R. K. Jain. 2000. Angiogenesis in cancer and other diseases. Nature 407:249-257.
8. Carmeliet, P., M.-G. Lampugnani, L. Moons, F. Breviaro, V. Compernolle, F. Bono, G. Balconi, R. Spagnuolo, B. Oosthuyse, M. Dewerchin, A. Zanetti, A. Angellilo, V. Mattot, D. Nuyens, E. Lutgens, F. Clotman, M. C. de Ruiter, A. Gittenberger-de Groot, R. Poelmann, F. Lupu, J.-M. Herbert, D. Collen, and E. Dejana. 1999. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell 98:147-157.
9. Chen, J., P. R. Somanath, O. Razorenova, W. Chen, N. Hay, P. Bornstein, and T. Byzova. 2005. Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo. Nat. Med. 11:1188-1196.
10. Dance, M., A. Montagner, A. Yart, B. Masri, Y. Audigier, B. Perret, J.-P. Salles, and P. Raynal. 2006. The adaptor protein Gab1 couples the stimulation of vascular endothelial growth factor receptor-2 to the activation of phosphoinositide 3-kinase. J. Biol. Chem. 281:23285-23295.
11. de laFuente-Garcia, M., J. Nicolas, J.Freed,E.Palou, A. Thomas,R. Vilella, J. Vives, and A. Gaya. 1998. CD148 is a membrane protein tyrosine phosphatase present in all hematopoietic lineages and is involved in signal transduction on lymphocytes. Blood 91:2800-2809.
12. Dixit, M., A. E. Loot, A. Mohamed, B. Fisslthaler, C. M. Boulanger, B. Ceacareanu, A. Hassid, R. Busse, and I. Fleming. 2005. Gab1, SHP2, and protein kinase A are crucial for the activation of the endothelial NO synthase by fluid shear stress. Circ. Res. 97:1236-1244.
13. Eliceiri, B. P., R. Paul, P. L. Schwartzberg, J. D. Hood, J. Leng, and D. A. Cheresh. 1999. Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. Mol. Cell 4:915-924.
14. Ferrara, N. 2005. The role of VEGF in the regulation of physiological and pathological angiogenesis, p. 209-231. In M. Clauss and G. Breier (ed.), Mechanisms of angiogenesis. Birkhäuser Verlag, Basel, Switzerland.
15. Ferrara, N., H.-P. Gerber, and J. LeCouter. 2003. The biology of VEGF and its receptors. Nat. Med. 9:669-676.
16. Folkman, J. 1995. Angiogenesis in cancer, vasculature, rheumatoid and other diseases. Nat. Med. 1:27-31.
17. Frisch, S. M., K. Vuori, E. Ruoslahti, and P. Y. Chan-Hui. 1996. Control of adhesion-dependent cell survival by focal adhesion kinase. J. Cell Biol. 134: 793-799.
18. Fujio, Y., and K. Walsh. 1999. Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner. J. Biol. Chem. 274:16349-16354.
19. Fulton, D., J.-P. Gratton, T. J. McCabe, J. Fontana, Y. Fujio, K. Walsh, T. F. Franke, A. Papapetropoulos, and W. C. Sessa. 1999. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399:597-601.
20. Fulton, D., J.-P. Gratton, and W. C. Sessa. 2001. Post-translational control of endothelial nitric oxide synthase: why isn't calcium/calmodulin enough? J. Pharmacol. Exp. Ther. 299:818-824.
21. Gerber, H. P., A. McMurtrey, J. Kowalski, M. Yan, B. A. Keyt, V. Dixit, and N. Ferrara. 1998. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. J. Biol. Chem. 273:30336-30343.
22. Guo, D., Q. Jia, H.-Y. Song, R. S. Warren, and D. B. Donner. 1995. Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. J. Biol. Chem. 270:6729-6733.
23. Ha, C. H., A. M. Bennett, and Z.-G. Jin. 2008. A novel role of vascular endothelial cadherin in modulating c-Src activation and downstream signaling of vascular endothelial growth factor. J. Biol. Chem. 283:7261-7270.
24. He, H., V. J. Venema, X. Gu, R. C. Venema, and M. B. Marrero. 1999. Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through Flk/KDR activation of c-Src. J. Biol. Chem. 274:25130-25135.
25. Holsinger, L. J., K. Ward, B. Duffield, J. Zachwieja, and B. Jallal. 2002. The transmembrane receptor protein tyrosine phosphatase DEP1 interacts with p120ctn. Oncogene 21:7067-7076.
26. Honda, H., J. Inazawa, J. Nishida, Y. Yazaki, and H. Hirai. 1994. Molecular cloning, characterization, and chromosomal localization of a novel protein-tyrosine phosphatase, HPTP eta. Blood 84:4186-4194.
27. Hungerford, J. E., M. T. Compton, M. L. Matter, B. G. Hoffstrom, and C. A. Otey. 1996. Inhibition of pp125FAK in cultured fibroblasts results in apoptosis. J. Cell Biol. 135:1383-1390.
28. Huyer, G., S. Liu, J. Kelly, J. Moffat, P. Payette, B. Kennedy, G. Tsaprailis, M. J. Gresser, and C. Ramachandran. 1997. Mechanism of inhibition of protein-tyrosine phosphatases by vanadate and pervanadate. J. Biol. Chem. 272:843-851.
29. Ichaso, N., and S. M. Dilworth. 2001. Cell transformation by the middle T-antigen of polyoma virus. Oncogene 20:7908-7916.
30. Iervolino, A., R. Iuliano, F. Trapasso, G. Viglietto, R. M. Melillo, F. Carlomagno, M. Santoro, and A. Fusco. 2006. The receptor-type protein tyrosine phosphatase J antagonizes the biochemical and biological effects of RET-derived oncoproteins. Cancer Res. 66:6280-6287.
31. Keane, M., G. Lowrey, S. Ettenberg, M. Dayton, and S. Lipkowitz. 1996. The protein tyrosine phosphatase DEP-1 is induced during differentiation and inhibits growth of breast cancer cells. Cancer Res. 56:4236-4243.
32. Khurana, R., M. Simons, J. F. Martin, and I. C. Zachary. 2005. Role of angiogenesis in cardiovascular disease: a critical appraisal. Circulation 112:1813-1824.
33. Kovalenko, M., K. Denner, J. Sandström, C. Persson, S. Gross, E. Jandt, R. Vilella, F. Böhmer, and A. Ostman. 2000. Site-selective dephosphorylation of the platelet-derived growth factor beta-receptor by the receptor-like protein-tyrosine phosphatase DEP-1. J. Biol. Chem. 275:16219-16226.
34. Lampugnani, M. G., A. Zanetti, M. Corada, T. Takahashi, G. Balconi, F. Breviario, F. Orsenigo, A. Cattelino, R. Kemler, T. O. Daniel, and E. Dejana. 2003. Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, β-catenin, and the phosphatase DEP-1/CD148. J. Cell Biol. 161:793-804.
35. Laramée, M., C. Chabot, M. Cloutier, R. Stenne, M. Holgado-Madruga, A. J. Wong, and I. Royal. 2007. The scaffolding adapter Gab1 mediates vascular endothelial growth factor signaling and is required for endothelial cell migration and capillary formation. J. Biol. Chem. 282:7758-7769.
36. Le Pera, I., R. Iuliano, T. Florio, C. Susini, F. Trapasso, M. Santoro, L. Chiariotti, G. Schettini, G. Viglietto, and A. Fusco. 2005. The rat tyrosine phosphatase η increases cell adhesion by activating c-Src through dephosphorylation of its inhibitory phosphotyrosine residue. Oncogene 24:3187-3195.
37. Manning, B. D., and L. C. Cantley. 2007. AKT/PKB signaling: navigating downstream. Cell 129:1261-1274.
38. Michell, B. J., J. E. Griffiths, K. I. Mitchelhill, I. Rodriguez-Crespo, T. Tiganis, S. Bozinovski, P. R. O. de Montellano, B. E. Kemp, and R. B. Pearson. 1999. The Akt kinase signals directly to endothelial nitric oxide synthase. Curr. Biol. 9:845-848.
39. Motley, E. D., K. Eguchi, M. M. Patterson, P. D. Palmer, H. Suzuki, and S. Eguchi. 2007. Mechanism of endothelial nitric oxide synthase phosphorylation and activation by thrombin. Hypertension 49:577-583.
40. Munshi, N., J. E. Groopman, P. S. Gill, and R. K. Ganju. 2000. c-Src mediates mitogenic signals and associates with cytoskeletal proteins upon vascular endothelial growth factor stimulation in Kaposi's sarcoma cells. J. Immunol. 164:1169-1174.
41. Olsson, A.-K., A. Dimberg, J. Kreuger, and L. Claesson-Welsh. 2006. VEGF receptor signalling; in control of vascular function. Nat. Rev. Mol. Cell Biol. 7:359-371.
42. Ong, S. H., S. Dilworth, I. Hauck-Schmalenberger, T. Pawson, and F. Kiefer. 2001. ShcA and Grb2 mediate polyoma middle T antigen-induced endothelial transformation and Gab1 tyrosine phosphorylation. EMBO J. 20:6327-6336.
43. Ostman, A., Q. Yang, and N. Tonks. 1994. Expression of DEP-1, a receptorlike protein-tyrosine-phosphatase, is enhanced with increasing cell density. Proc. Natl. Acad. Sci. USA 91:9680-9684.
44. Palka, H. L., M. Park, and N. K. Tonks. 2003. Hepatocyte growth factor receptor tyrosine kinase Met is a substrate of the receptor protein-tyrosine phosphatase DEP-1. J. Biol. Chem. 278:5728-5735.
45. Risau, W. 1997. Mechanisms of angiogenesis. Nature 386:671-674.
46. Royal, I., N. Lamarche-Vane, L. Lamorte, K. Kaibuchi, and M. Park. 2000. Activation of Cdc42, Rac, PAK and Rho-kinase in response to hepatocyte growth factor differentially regulate epithelial cell colony spreading and dissociation. Mol. Biol. Cell 11:1709-1725.
47. Ruivenkamp, C. A. L., T. van Wezel, C. Zanon, A. P. M. Stassen, C. Vlcek, T. Csikos, A. M. Klous, N. Tripodis, A. Perrakis, L. Boerrigter, P. C. Groot, J. Lindeman, W. J. Mooi, G. A. Meijjer, G. Scholten, H. Dauwerse, V. Paces, N. van Zandwijk, G. J. B. van Ommen, and P. Demant. 2002. Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers. Nat. Genet. 31:295-300.
48. Summers, S. A., L. Lipfert, and M. J. Birnbaum. 1998. Polyoma middle T antigen activates the Ser/Thr kinase Akt in a PI3-kinase-dependent manner. Biochem. Biophys. Res. Commun. 246:76-81.
49. Takahashi, T., K. Takahashi, R. Mernaugh, V. Drozdoff, C. Sipe, H. Schoecklmann, B. Robert, D. R. Abrahamson, and T. O. Daniel. 1999. Endothelial localization of receptor tyrosine phosphatase, ECRTP/DEP-1, in developing and mature renal vasculature. J. Am. Soc. Nephrol. 10:2135-2145.
50. Takahashi, T., K. Takahashi, P. L. St. John, P. A. Fleming, T. Tomemori, T. Watanabe, D. R. Abrahamson, C. J. Drake, T. Shirasawa, and T. O. Daniel. 2003. A mutant receptor tyrosine phosphatase, CD148, causes defects in vascular development. Mol. Cell. Biol. 23:1817-1831.
51. Kip1. Mol. Cell. Biol. 20:9236-9246.
52. Tsujikawa, K., T. Ichijo, K. Moriyama, N. Tadotsu, K. Sakamoto, N. Sakane, S.-i. Fukada, T. Furukawa, H. Saito, and H. Yamamoto. 2002. Regulation of Lck and Fyn tyrosine kinase activities by transmembrane protein tyrosine phosphatase leukocyte common antigen-related molecule. Mol. Cancer Res. 1:155-163.
53. Xia, P., L. P. Aiello, H. Ishii, Z. Y. Jiang, D. J. Park, G. S. Robinson, H. Takagi, W. P. Newsome, M. R. Jirousek, and G. L. King. 1996. Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoform, and endothelial cell growth. J. Clin. Investig. 9:2018-2026.
54. Zhang, L., M. Martelli, C. Battaglia, F. Trapasso, D. Tramontano, G. Viglietto, A. Porcellini, M. Santoro, and A. Fusco. 1997. Thyroid cell transformation inhibits the expression of a novel rat protein tyrosine phosphatase. Exp. Cell Res. 235:62-70.
55. Zhu, J. W., T. Brdicka, T. R. Katsumoto, J. Lin, and A. Weiss. 2008. Structurally distinct phosphatases CD45 and CD148 both regulate B cell and macrophage immunoreceptor signaling. Immunity 28:183-196.